Financial reports
NT 10-K
Notice of late annual filing
1 Nov 21
10-Q
2021 Q3
Quarterly report
21 Jun 21
NT 10-Q
Notice of late quarterly filing
14 Jun 21
10-Q
2021 Q2
Quarterly report
17 Mar 21
10-Q
2020 Q1
Quarterly report
21 Dec 20
NT 10-Q
Notice of late quarterly filing
15 Dec 20
10-K
2020 FY
Annual report
13 Nov 20
NT 10-K
Notice of late annual filing
29 Oct 20
10-K/A
2019 FY
Annual report (amended)
29 Jun 20
10-Q
2020 Q3
Quarterly report
22 Jun 20
Current reports
8-K
Other Events
23 Jul 21
8-K
Entry into a Material Definitive Agreement
21 Jul 21
8-K
Other Events
12 May 21
8-K
Other Events
29 Apr 21
8-K
Other Events
27 Apr 21
8-K
Entry into a Material Definitive Agreement
23 Feb 21
8-K
Other Events
19 Feb 21
8-K
Other Events
10 Feb 21
8-K
Other Events
2 Feb 21
8-K
Entry into a Material Definitive Agreement
8 Jan 21
Registration and prospectus
424B3
Prospectus supplement
21 Sep 20
424B3
Prospectus supplement
18 Sep 20
S-1/A
IPO registration (amended)
14 Sep 20
D
Indefinite amount in equity / options / securities to be acquired, sold $2M, 3 investors
11 Sep 20
S-1/A
IPO registration (amended)
9 Sep 20
S-1/A
IPO registration (amended)
3 Sep 20
S-1
IPO registration
20 Aug 20
AW
Withdrawal of amendment
19 Jun 20
S-1/A
IPO registration (amended)
15 Jun 20
S-1/A
IPO registration (amended)
15 Jun 20
Proxies
DEF 14A
Definitive proxy
24 Sep 19
DEFA14A
Additional proxy soliciting materials
6 Nov 17
DEF 14A
Definitive proxy
13 Oct 17
PRER14A
Preliminary revised proxy
8 Aug 17
PRE 14A
Preliminary proxy
18 Apr 17
DEFR14A
Revised proxy
14 Jul 15
DEF 14A
Definitive proxy
7 Jul 15
PRER14A
Preliminary revised proxy
25 Jun 15
PRE 14A
Preliminary proxy
2 Jun 15
DEFR14A
Revised proxy
5 May 14
Other
SEC STAFF ACTION
SEC staff action: Order
10 Oct 23
SEC STAFF ACTION
SEC staff action: Order
10 Oct 23
REVOKED
Registration or securities revoked
30 Jan 23
EFFECT
Notice of effectiveness
15 Sep 20
EFFECT
Notice of effectiveness
15 Sep 20
CORRESP
Correspondence with SEC
11 Sep 20
CORRESP
Correspondence with SEC
11 Sep 20
CORRESP
Correspondence with SEC
9 Sep 20
UPLOAD
Letter from SEC
8 Sep 20
CORRESP
Correspondence with SEC
3 Sep 20
Ownership
SC 13G/A
Beneficial ownership report (amended)
13 Feb 20
SC 13G
Generex Biotechnology Corp
29 Nov 19
3
Mark Joseph SE Prioletti
11 Sep 19
3
Lawrence Anthony Salvo Sr
14 May 19
4
Harold Gray Haines
14 Dec 18
4
Harold Gray Haines
14 Dec 18
SC 13G/A
Generex Biotechnology Corp
6 Nov 18
SC 13G/A
Generex Biotechnology Corp
6 Nov 18
4
Andrew Ro
15 Oct 18
4
Richard David Jr. Purcell
15 Oct 18